Our award-winning reporting has moved

Context provides news and analysis on three of the world’s most critical issues:

climate change, the impact of technology on society, and inclusive economies.

Cuba says Abdala vaccine 92.28% effective against coronavirus

by Reuters
Tuesday, 22 June 2021 00:18 GMT

(Fixes spelling of Soberana, paragraph 2)

HAVANA, June 21 (Reuters) - Cuba said on Monday its three-shot Abdala vaccine against the coronavirus had proved 92.28% effective in last-stage clinical trials.

The announcement came just days after the government said another homegrown vaccine, Soberana II, had proved 62% effective.

(Reporting by Marc Frank; Editing by Peter Cooney)

Our Standards: The Thomson Reuters Trust Principles.